Randomized crossover study in patients with neuroendocrine tumors to assess patient preference for lanreotide Autogel(®) given by either self/partner or a health care professional

BACKGROUND: Lanreotide Autogel(®) is supplied in prefilled syringes. Therefore, it is possible for patients with neuroendocrine tumors to use self-/partner-administered injections. The primary objective of this study was to assess the proportion of patients preferring self/partner injections over in...

Descripción completa

Detalles Bibliográficos
Autores principales: Johanson, Viktor, Wilson, Benedicte, Abrahamsson, Anna, Jianu, Constantin, Calissendorff, Jan, Wall, Najme, Grønbæk, Henning, Florholmen, Jon, Öhberg, Anders, Granberg, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484527/
https://www.ncbi.nlm.nih.gov/pubmed/23118529
http://dx.doi.org/10.2147/PPA.S34337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484527/
https://www.ncbi.nlm.nih.gov/pubmed/23118529
http://dx.doi.org/10.2147/PPA.S34337

Ejemplares similares